Clinical Trial Update: Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of topotecan for persistent or recurrent cervical cancer has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08